BEAT— "A heartbeat ahead"

The problem has been identified. The technology exists. What’s missing is the architecture that transforms health data into timely medical decisions, anywhere in the world. BEAT is that architecture

BIOMETRIC EVALUATION AND ACCESIBLE TELEMEDICINE

Our Strategic Partner
Current Status of the Initiative

Phase 0 (documentary structuring) completed. The initiative is currently on hold at the discretion of its owner, pending the conditions to launch Phase 1
For additional or detailed information, please contact ERGOSPORT SAS - Colombia

Structuring the Ready-to-Execute Operating Model:
KEATON

KEATON International Consulting Group, through its Strategic and Business Intelligence Unit, designed the architecture and structuring of Phase 0 of the BEAT Initiative (Biometric Evaluation and Accessible Telemedicine): an operating model built to be standard, scalable and adaptable across countries, regions and health systems, with a focus on the efficient use of any cooperation and financing resources the Initiative may access.

The promise of a healthcare model that anticipates illness rather than reacting to it

The Scientific Origin: The Perspective of DR. JOHNNY ALDER IZQUIERDO
ERGOSPORT

BEAT emerged from the real-world clinical practice of Dr. Johnny Alder Izquierdo, a cardiologist and specialist in internal medicine, through his organization ERGOSPORT His clinical work on the Autonomic Nervous System (ANS)—the great silent regulator of the stress response and, by extension, of a large portion of noncommunicable diseases (NCDs)—allowed him to identify something that the wearables industry had not yet fully grasped: health sensors already capture the biometric indicators necessary for a comprehensive diagnosis, but no one is integrating them for a real clinical purpose. This medical—not technological —interpretation of the problem is BEAT’s foundational intellectual asset: it transforms a generic monitoring device into an architecture for timely clinical decision-making. It is this clinical vision, validated by years of practice and evidence with patients, that today translates into the intellectual property of the diagnostic model and the initiative’s Medical-Scientific Directorate

Do You Have a Project and Don't Know How to Structure It and Access Financing?

LET'S DO IT TOGETHER
Your Project HERE, With Us!